Monkeypox: A review of a zoonotic disease of global public health concern.

Background: The rising circulation of the monkeypox virus while the COVID-19 is still ongoing in non-endemic countries is a significant global health threat. In this article, we have discussed the epidemiology, aetiology, and pathogenesis of the monkeypox virus to provide our current knowledge of the disease. Also, we discussed the ongoing efforts of the international health organizations to curtail the present epidemic and we finally provide recommendations for early detection and response. Methods: We did a rapid literature search on PubMed, EMBASE, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other trusted databases for recent articles (1958-2022) published in English-focusing on the outbreaks of monkeypox disease, epidemiology, pathogenesis, aetiology, prevention, and control in endemic and non-endemic countries. Keywords such as "Monkeypox", "Monkeypox virus", "Poxviridae", "Orthopoxvirus", "Smallpox", and "Smallpox Vaccine" were considered in our search based on MESH medical subject headings. Results: Our review highlights four important findings. First, a cumulative of 1285 monkeypox cases have been documented and reported by the WHO in non-endemic countries as of June 8, 2022. Second, international travel contributes to the increase in cases in non-endemic countries. Third, the origin of the outbreak, the pattern of transmission, and the risk of infections is not fully understood. Fourth, there is an ongoing effort by the WHO, CDC, and other international health organization to control the spread of the monkeypox disease. Conclusion: Our findings underline the need to reassess research priorities on the origin, transmission pattern, and risk factors for infection of monkeypox. Also, we provide recommendations under the One Health spectrum to prevent further spread of the disease.

Preventing the Next Pandemic through a Planetary Health Approach: A Focus on Key Drivers of Zoonosis

The ever-increasing global health impact of SARS-CoV-2-the etiological agent of coronavirus disease 2019 (COVID-19)-coupled with its socio-economic burden, has not only revealed the vulnerability of humanity to zoonotic pathogens of pandemic potential but also serves as a wake-up call for global health communities to rethink sustainable approaches towards preventing future pandemics. However, since the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES) convened experts have declared that future pandemics are likely to be zoonotic in origin, it is imperative that we understand the key drivers of zoonosis such as biodiversity loss, climate change, wildlife consumption, and population mobility, as well as the scientific evidence underpinning them. In this article, we underscore the correlations of these drivers with the emergence and re-emergence of zoonosis. Consequently, we highlighted the need for multidisciplinary collaboration under the planetary health approach between researchers across the fields of environmental and human health to fill the knowledge and research gaps on key drivers of zoonosis. This is to prevent or limit future pandemics by protecting the natural systems of the Earth and its resources and safeguarding human and animal health.

Zoonotic Spillover in an Era of Rapid Deforestation of Tropical Areas and Unprecedented Wildlife Trafficking: Into the Wild

Rapid deforestation and unprecedented wildlife trafficking are important factors triggering the rate of zoonotic spillover from animals to humans. Consequently, this leads to the emergence and re-emergence of zoonotic infectious diseases among the human population. Deforestation is an important ecological disruption that leads to the loss of biodiversity. The loss of biodiversity results in the persistence of highest-quality hosts of zoonotic pathogens dominating the low-diversity communities, a process termed the dilution effect. Activities like intensive farming and logging that resulted in deforestation bring vulnerable people in close contact with these highest-quality reservoir hosts (wildlife). As a result of this vulnerability, there is an increased risk of spillover, leading to zoonotic infection in humans and eventually disease outbreaks during human–human transmission. One prominent example of a disease of wildlife origin is the ongoing SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus 2), even though the original source has not been found. Another important factor facilitating the risk of spillover and emergence of zoonotic infectious diseases is wildlife trafficking. This involves illegal hunting and trading of wildlife and their products, which increases the risk of spillover as a result of exchange of bodily fluids and bloodmeals between humans and wildlife during the hunting and butchering of animals' carcasses. Consequently, little or no hygiene protocol and poor handling practices during the wildlife-trade chain expose poachers, consumers, and local market sellers to the risk of zoonotic diseases. Despite the interventions on deforestation-induced spillover and wildlife trafficking-associated spillover, there are still knowledge and research gaps that need to be addressed towards preventing the outbreaks of future zoonotic infectious diseases. In response to this, there is a need for interdisciplinary and intersectoral collaborations among researchers from various fields as well as sectors in minimizing the risk of zoonotic spillover driven by deforestation and wildlife trafficking at the human–animal–environmental nexus. In addition, there is a need for integrated and unified evidence-based policy formulation that puts an end to deforestation and wildlife trafficking, especially in tropical areas such as Africa and Asia.

Dengue virus and SARS-CoV-2 Co-infection dynamics: An emerging threat among African countries.

The rising circulation of the vector borne disease such as dengue fever amidst the COVID-19 pandemic in African countries is on the rise, which pose a significant public health threat. In this article, we discussed the co-infection of dengue virus (DENV) (the causative agent of dengue fever) and SARS-CoV-2 (the causative agents of COVID-19) as well as the associated risk factors involved. Our review highlights that the continuous increase in the incidence and disease mortality from the co-infection of dengue Virus and SARS-CoV-2 is as result of inadequate surveillance and limited testing centers. Second, the overlapping clinical features and indistinguishable symptoms from both infections is a major challenge. Third, lack of scientific prudence among stakeholders has played a significant impact on how to contain these diseases. Therefore, there is a need to reassess research priorities in understanding the risk factors involved from the coinfection. Also, the development of accurate point-of-care diagnostics for COVID-19 and dengue fever coupled with community-based health intervention programs is highly essential for control.

The Need to Prioritize Prevention of Viral Spillover in the Anthropopandemicene: A Message to Global Health Researchers and Policymakers

Increased anthropogenic activities including changes in land use and unrelenting ecosystem services related to animal husbandry, wildlife trade, and deforestation are driving the emergence of viral zoonosis. This is primarily due to human–animal interaction which is facilitating the spillover of viral zoonotic pathogens from animals (domestic and wildlife) to humans that could result in epidemics or pandemics. Scientific reports so far have revealed that viral epidemics and pandemics in recent years such as H1N1 Swine Influenza, H5N1 Avian Influenza, Ebola, Zika, Severe Acute Respiratory Syndrome (SARS), and the ongoing SARS-CoV-2 were all zoonotic, and their emergence has been linked with spillover events arising from human–animal interaction. This increased interaction and the increased spillover event could facilitate future pandemic risk, and the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services, 'IPBES';, has declared this 'the era of pandemics';. Furthermore, since future pandemics would be triggered by anthropogenic activities, we have called this 'anthropopandemicene';, i.e., an era of pandemics driven by anthropogenic activities. To minimize the risk of future pandemics, it is important to prioritize the prevention of viral spillover events. Here, we outline five priority areas for global health researchers and policymakers. These areas include improvement of biosecurity at livestock farms, imposing a moratorium or strictly banning wildlife trade that poses a public health risk, conservation of biodiversity by halting deforestation, investing in community-based research for infectious disease control, and strengthening community healthcare systems in precarious ecosystems and infectious diseases hotspots. Finally, we acknowledge the efforts of other renowned global and legally binding frameworks such as IHR, the Paris Agreement, and CITES with regard to addressing the public health risk of infectious diseases, and we provide recommendations for their improvement.